Intra-Cellular Therapies
ITCI
#1805
Rank
HK$70.49 B
Marketcap
HK$664.93
Share price
-2.53%
Change (1 day)
50.25%
Change (1 year)

Market capitalization of Intra-Cellular Therapies (ITCI)

Market cap: HK$70.49 Billion

As of November 2024 Intra-Cellular Therapies has a market cap of HK$70.49 Billion. This makes Intra-Cellular Therapies the world's 1805th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Intra-Cellular Therapies from 2013 to 2024

End of year Market Cap

Year Marketcap Change
2024HK$70.49 B30.95%
2023HK$53.83 B37.47%
2022HK$39.15 B17.78%
2021HK$33.24 B67.61%
2020HK$19.83 B33.73%
2019HK$14.83 B202.92%
2018HK$4.89 B-20.7%
2017HK$6.17 B21.95%
2016HK$5.06 B-71.86%
2015HK$17.99 B345.52%
2014HK$4.03 B17.51%
2013HK$3.43 B

End of Day market cap according to different sources

On Nov 14th, 2024 the market cap of Intra-Cellular Therapies was reported to be:

HK$72.32 Billion
by Nasdaq info icon info icon
HK$72.32 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HK$0.69 B-99.01%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.17 B-99.75%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$12.36 B-82.46%๐Ÿ‡บ๐Ÿ‡ธ USA